BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2017432)

  • 1. Design and synthesis of the pseudo-EF hand in calbindin D9K: effect of amino acid substitutions in the alpha-helical regions.
    Tsuji T; Kaiser ET
    Proteins; 1991; 9(1):12-22. PubMed ID: 2017432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of preferred binding domains on peptide retention behavior in reversed-phase chromatography: amphipathic alpha-helices.
    Zhou NE; Mant CT; Hodges RS
    Pept Res; 1990; 3(1):8-20. PubMed ID: 2134049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic model proteins: contribution of hydrophobic residues and disulfide bonds to protein stability.
    Hodges RS; Zhou NE; Kay CM; Semchuk PD
    Pept Res; 1990; 3(3):123-37. PubMed ID: 2134057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence and context dependence of EF-hand loop dynamics. An 15N relaxation study of a calcium-binding site mutant of calbindin D9k.
    Malmendal A; Carlstrom G; Hambraeus C; Drakenberg T; Forsen S; Akke M
    Biochemistry; 1998 Feb; 37(8):2586-95. PubMed ID: 9485409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disulfide bonds in homo- and heterodimers of EF-hand subdomains of calbindin D9k: stability, calcium binding, and NMR studies.
    Linse S; Thulin E; Sellers P
    Protein Sci; 1993 Jun; 2(6):985-1000. PubMed ID: 8318902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of side-chain characteristics on stability and oligomerization state of a de novo-designed model coiled-coil: 20 amino acid substitutions in position "d".
    Tripet B; Wagschal K; Lavigne P; Mant CT; Hodges RS
    J Mol Biol; 2000 Jul; 300(2):377-402. PubMed ID: 10873472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The solution structures of mutant calbindin D9k's, as determined by NMR, show that the calcium-binding site can adopt different folds.
    Johansson C; Ullner M; Drakenberg T
    Biochemistry; 1993 Aug; 32(33):8429-38. PubMed ID: 8357794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A calbindin D9k mutant containing a novel structural extension: 1H nuclear magnetic resonance studies.
    Groves P; Linse S; Thulin E; Forsén S
    Protein Sci; 1997 Feb; 6(2):323-30. PubMed ID: 9041633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Domain organization of calbindin D28k as determined from the association of six synthetic EF-hand fragments.
    Linse S; Thulin E; Gifford LK; Radzewsky D; Hagan J; Wilk RR; Akerfeldt KS
    Protein Sci; 1997 Nov; 6(11):2385-96. PubMed ID: 9385641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two conformational states of Turkey ovomucoid third domain at low pH: three-dimensional structures, internal dynamics, and interconversion kinetics and thermodynamics.
    Song J; Laskowski M; Qasim MA; Markley JL
    Biochemistry; 2003 Jun; 42(21):6380-91. PubMed ID: 12767219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orientation, positional, additivity, and oligomerization-state effects of interhelical ion pairs in alpha-helical coiled-coils.
    Kohn WD; Kay CM; Hodges RS
    J Mol Biol; 1998 Nov; 283(5):993-1012. PubMed ID: 9799639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactam bridge stabilization of alpha-helical peptides: ring size, orientation and positional effects.
    Houston ME; Gannon CL; Kay CM; Hodges RS
    J Pept Sci; 1995; 1(4):274-82. PubMed ID: 9223005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrophobic core substitutions in calbindin D9k: effects on stability and structure.
    Julenius K; Thulin E; Linse S; Finn BE
    Biochemistry; 1998 Jun; 37(25):8915-25. PubMed ID: 9636033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrophobic core substitutions in calbindin D9k: effects on Ca2+ binding and dissociation.
    Kragelund BB; Jönsson M; Bifulco G; Chazin WJ; Nilsson H; Finn BE; Linse S
    Biochemistry; 1998 Jun; 37(25):8926-37. PubMed ID: 9636034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional evidence for an intramolecular side chain interaction between residues 6 and 10 of receptor-bound parathyroid hormone analogues.
    Shimizu N; Petroni BD; Khatri A; Gardella TJ
    Biochemistry; 2003 Mar; 42(8):2282-90. PubMed ID: 12600195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein design using model synthetic peptides.
    Hodges RS; Semchuk PD; Taneja AK; Kay CM; Parker JM; Mant CT
    Pept Res; 1988; 1(1):19-30. PubMed ID: 2980779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering new metal specificity in EF-hand peptides.
    Le Clainche L; Plancque G; Amekraz B; Moulin C; Pradines-Lecomte C; Peltier G; Vita C
    J Biol Inorg Chem; 2003 Feb; 8(3):334-40. PubMed ID: 12589569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constrained corticotropin-releasing factor (CRF) agonists and antagonists with i-(i+3) Glu-Xaa-DXbb-Lys bridges.
    Koerber SC; Gulyas J; Lahrichi SL; Corrigan A; Craig AG; Rivier C; Vale W; Rivier J
    J Med Chem; 1998 Dec; 41(25):5002-11. PubMed ID: 9836618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational study of silk-like peptides containing the calcium-binding sequence from calbindin D9k using 13C CP/MAS NMR spectroscopy.
    Asakura T; Hamada M; Nakazawa Y; Ha SW; Knight DP
    Biomacromolecules; 2006 Feb; 7(2):627-34. PubMed ID: 16471940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of increased length and intact capping sequences to the conformational preference for helix in a 31-residue peptide from the C terminus of myohemerythrin.
    Reymond MT; Huo S; Duggan B; Wright PE; Dyson HJ
    Biochemistry; 1997 Apr; 36(17):5234-44. PubMed ID: 9136885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.